........the shorts are ALSO benefiting by writing the LEAPS. Understand that back in Oct when OPK went into the $11s-12s, many diehard Longs bought the Jan15, $10 LEAPS like there was no tomorrow. Now (thanks to BOZZO, and probably a major writer of those LEAPS), the premium on those LEAPS have been decimated and are fast approaching ZERO. Those Longs will probably lose ALL their LEAP investment while the shorts, or the writers of those LEAPS, are smiling all the way to the bank, so don't expect this stock to trade above $10 for any relative period of time for the remainder of this year. Bottom line, OPK is a 2015 story!
I'm am not worried one bit! I own 2015 and 2016 10, 12, and 15's. why am I not worried??? Because Rayaldy is going to get this up to atleast 12-15! Lot of people bought those higher calls in order to pay to exercise lower calls to own even more! You play biotech stocks on pops and falls, but you only see it from the short side!
Longs and shorts can win if they play it right. I pick the long side because of more upside and less risk, you don't want to be caught in the coming squeeze for sure!! If you are short at the wrong time you WILL be decimated.